Detalhe da pesquisa
1.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 170(6): 1109-1119.e10, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886381
2.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 174(4): 1031-1032, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096300
3.
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
BMC Cancer
; 23(1): 1000, 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853341
4.
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
J Surg Oncol
; 127(5): 815-822, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629137
5.
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 20(4): 518-530, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857956
6.
Aging and osteoporosis in breast and prostate cancer.
CA Cancer J Clin
; 61(3): 139-56, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21543824
7.
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Br J Haematol
; 178(2): 250-256, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419413
8.
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol
; 16(2): 221-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596659
9.
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol
; 16(2): 208-20, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596660
10.
Next-Generation Sequencing and In Silico Analysis Facilitate Prolonged Response to Pazopanib in a Patient With Metastatic Urothelial Carcinoma of the Renal Pelvis.
J Natl Compr Canc Netw
; 13(10): 1181-5, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483058
11.
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
Sci Rep
; 14(1): 3444, 2024 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341515
12.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Cancer Res Commun
; 4(5): 1369-1379, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709075
13.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Cancer Discov
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564707
14.
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.
Front Oncol
; 13: 1215524, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700839
15.
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
NPJ Precis Oncol
; 7(1): 120, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964004
16.
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
J Clin Oncol
; 41(3): 528-540, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998300
17.
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
Nat Med
; 29(9): 2278-2285, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592104
18.
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events.
Clin Lung Cancer
; 23(8): 686-693, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050243
19.
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.
Mol Cancer Ther
; 21(1): 227-236, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725190
20.
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.
J Geriatr Oncol
; 13(3): 294-301, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756496